CTLA4 Immunoglobulin but Not Anti–Tumor Necrosis Factor Therapy Promotes Staphylococcal Septic Arthritis in Mice

Antibiotic-KilledStaphylococcus aureusInduces Destructive Arthritis in Mice

(2014) Abukar Ali et al.   Arthritis & Rheumatology

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial

(2013) Michael Schiff et al.   ANNALS OF THE RHEUMATIC DISEASES

Staphylokinase Promotes the Establishment of Staphylococcus aureus Skin Infections While Decreasing Disease Severity

(2013) Jakub Kwiecinski et al.   JOURNAL OF INFECTIOUS DISEASES

Deleterious Effect of CTLA4-Ig on a Treg-Dependent Transplant Model

(2012) L. V. Riella et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Macrophage plasticity and polarization: in vivo veritas

(2012) Antonio Sica et al.   JOURNAL OF CLINICAL INVESTIGATION

The Combination of a Tumor Necrosis Factor Inhibitor and Antibiotic Alleviates Staphylococcal Arthritis and Sepsis in Mice

(2011) Ying Fei et al.   JOURNAL OF INFECTIOUS DISEASES

Dexamethasone Therapy for Septic Arthritis in Children

(2011) Liora Harel et al.   JOURNAL OF PEDIATRIC ORTHOPAEDICS

Safety profile of abatacept in rheumatoid arthritis: A review

(2010) Majed Khraishi et al.   CLINICAL THERAPEUTICS

TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P

(2010) Lynne A. Murray et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells

(2009) Shomyseh Sanjabi et al.   IMMUNITY

IL-4 Deficiency Decreases Mortality but Increases Severity of Arthritis in Experimental Group BStreptococcusInfection

(2009) Luciana Tissi et al.   MEDIATORS OF INFLAMMATION

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials

(2008) C Salliot et al.   ANNALS OF THE RHEUMATIC DISEASES

Effects of three anti-TNF-α drugs: Etanercept, infliximab and pirfenidone on release of TNF-α in medium and TNF-α associated with the cell in vitro

(2008) K.J. Grattendick et al.   INTERNATIONAL IMMUNOPHARMACOLOGY